Physician profile
Jonathan J Werner
NPI 1619474228
$1,010.63
in general payments reported to CMS, 2019-2025
15 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.29 · 2023: $312 · 2024: $333 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $409.02 | 2023-2025 | Mounjaro, Zepbound, Basaglar |
| Amgen INC. | $107.29 | 2024-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $100.31 | 2023-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $80.13 | 2023-2025 | |
| Exact Sciences Corporation | $79.83 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Vertex Pharmaceuticals Incorporated | $48.97 | 2025 | |
| Daiichi Sankyo INC. | $37.78 | 2023-2024 | Injectafer |
| Astellas Pharma US INC | $22.29 | 2022 | |
| Medtronic, INC. | $22.05 | 2024 | Minimed 780g |
| Inspire Medical Systems, INC. | $19.52 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $19.46 | 2023 | |
| Abbvie INC. | $18.01 | 2025 | |
| Axonics, INC. | $17.71 | 2024 | Axonics |
| Astrazeneca Pharmaceuticals LP | $14.30 | 2023 | Farxiga |
| Convatec INC. | $13.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Werner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.